Gabapentin
Product Images NDC 63304-628

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63304-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Contain100 (Contain100)

This is a medication called Gabapentin, which comes in capsule form. Pharmacists should provide the accompanying medication guide to each patient who receives this prescription. The NDC number for this medication is 63304-627-0. It is only available with a prescription.*

FDA Label Image

300 mg Bottle Label (Contain300)

This is a prescription drug called Gabapentin capsules, which come in a bottle of 100 capsules. The pharmacist is advised to dispense a Medication Guide to each patient who receives this drug.*

FDA Label Image

Contain400 (Contain400)

This is a medication called Gabapentin, in the form of capsules. It is only available with a prescription, and it comes with a medication guide that should be given to each patient by the pharmacist. The quantity mentioned is 100 capsules.*

FDA Label Image

Figure 1 (Figure1)

The text provides information about mean pain score, with a value of 10. There are references to "Voo Dos Trsion Paied," "Oplacebs," and "Gabapantin, 3800 moiday," which suggest that the data may come from a study or clinical trial evaluating pain relief treatments. There is also a table or graph with columns labeled "Bidbe," "4," "3," "A," "s," and "1," but it is unclear what this information represents. Overall, without further context it is difficult to provide a more detailed description.*

FDA Label Image

Figure 2 (Figure2)

This appears to be a chart or graph displaying the dosing regimen for two different periods of gabapentin treatment, one 3-week dose titration period and one 8-week fixed dose period. The chart displays the dosage amount in milligrams per day, increasing from 1800 mg/day to 2400 mg/day during the titration period. The chart is labeled with a scale counting weeks.*

FDA Label Image

Figure 3 (Figure3)

The text seems to be a chart displaying the percentage of responders at an endpoint for Study 1 and Study 2. The chart appears to show that Study 1 had a higher percentage of responders at the endpoint compared to Study 2. The text does not provide any details about what the study is about or what the endpoint is.*

FDA Label Image

Figure 4 (Figure4)

FDA Label Image

Mstructure (Mstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.